DUBLIN--(BUSINESS WIRE)--The "Electrophoresis Reagents Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
The propelling factors for the growth of the electrophoresis reagents market include the increased funding for genomic and proteomic research, the rising prevalence of chronic diseases, increasing collaborations between industry and academics, and the technological developments.
The prevalence of chronic diseases is expected to increase by 57% by 2020. Additionally, as per WHO, China and India now have the world's highest number of diabetes sufferers at more than 98 million and 65 million individuals. With the increasing prevalence of chronic diseases, prompt diagnosis and treatment are in need.
Therefore, this has given rise to the electrophoresis that is used in the clinical laboratories to quantify the lipoproteins using enzymatic staining of cholesterol and triglycerides for the diagnosis of CVD and other chronic diseases, like diabetes. The electrophoresis is used in the analysis of the lipoproteins and apolipoproteins that are essential for the valuation of the CVD and monitoring of individuals on treatment.
Furthermore, the development of this market is also significantly determined by the expanding research exercises in the fields of proteomics and genomics, changing administrative necessities in the pharmaceutical part, and the developing need to reduce the healthcare expenses.
Moreover, factors like rising per capita income and increasing public healthcare expenditure are also expected to promote the growth of electrophoresis reagents market over the forecast period.
Key Market Trends
Gel Electrophoresis is the Largest Segment Under Technique That is Also Expected to Continue During the Forecast Period
Gel electrophoresis segment accounted for the largest market share of electrophoresis reagents market, mainly due to the low operating and instrument cost. It is, thus, being followed by capillary electrophoresis, because of rising applications in the pharmaceutical and biotechnology industries.
Asia-Pacific Region is the Fastest Growing Market and is Expected to Follow the Same Trend Over the Forecast Period
The Asia-Pacific region is expected to dominate the electrophoresis reagents market. In the emerging economies of China, Japan, and India, there has been an increasing number of academic and research institutions, technological advancements, pharmaceutical, and biotechnology companies, and health awareness. The high growth is also majorly attributed to the rapidly improving healthcare infrastructure and low labor costs in emerging countries.
The major players are found adopting various strategies, such as agreements, expansion, contracts, partnerships, new reagent development, joint ventures, and mergers and acquisitions in order to strengthen their position in the electrophoresis reagents market.
Key Topics Covered
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Funding for Genomic and Proteomic Research
4.2.2 Rising Prevalence of Chronic Diseases
4.2.3 Increasing Collaborations between Industry and Academics
4.2.4 Technological Developments
4.3 Market Restraints
4.3.1 Time-consuming Operations
4.3.2 Presence of Alternative Technologies
4.4 Porter's Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Product
220.127.116.11 Agarose Gels
18.104.22.168 Polyacrylamide Gels
22.214.171.124 Starch Gels
126.96.36.199 Ethidium Bromide (ETBR) Dyes
188.8.131.52 Bromophenol Blue
184.108.40.206 Sybr Dyes
220.127.116.11 Other Dyes
18.104.22.168 Other Buffers
5.1.4 Other Products
5.2 By Technique
5.2.1 Gel Electrophoresis
5.2.2 Capillary Electrophoresis
5.3 By End User
5.3.1 Academic and Research Institutions
5.3.2 Pharmaceutical and Biotechnology Companies
5.3.4 Other End Users
5.4.1 North America
5.4.4 Middle East & Africa
5.4.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.3 Bio-Rad Laboratories Inc.
6.1.4 GE Healthcare
6.1.5 Lonza Group AG
6.1.6 Merck KGaA
6.1.7 Qiagen N.V.
6.1.8 Sigma-Aldrich Corporation
6.1.9 Takara Bio Inc.
6.1.10 Thermo Fisher Scientific
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/afzbzo